Effect of polyopes lancifolia extract on oxidative stress in human umbilical vein endothelial cells induced by high glucose

Preventive Nutrition and Food Science

Volumn 18, Issue 1, 2013, Pages 38-44

  Min, Seong Won ^a   Han, Ji Sook ^a  

^a Pusan National University   (South Korea)

Author keywords

High glucose; HUVECs; Oxidative stress; Polyopes lancifolia; Protective effects

Indexed keywords

EID: 84881272638     PISSN: 22871098     EISSN: 22878602     Source Type: Journal    
DOI: 10.3746/pnf.2013.18.1.038     Document Type: Article

References (37)

1. Corry DB, Tuck ML. 2000. Protection from vascular risk in diabetic by pretension. Curr Hypertens Rep 2: 154-159.
2. Krentz AJ, Clough G, Byren CD. 2007. Interaction between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab 9: 781-791.
3. World Health Organization (WHO). Update 2012. http:// www.who.int/mediacentre/factsheets/fs312/en/.
4. Kaplan M, Aviram M, Hayek T. 2012. Oxidative stress and macrophage foam cell formation during diabetes mellitusinduced atherogenesis: Role of insulin therapy. Pharmacol Ther 136: 175-185.
5. Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the debelopment and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977- 986.
6. Hiramatsu K, Arimori S. 1998. Increased superoxide production by mononuclear cells of patients with hypertryglycerdemia and diabetes. Diabetes 37: 832-837.
7. Van Dam PS, Van Asbeck BS, Van Oirschot JF, Biessels GJ, Hamers FP, Marx JJ. 2001. Glutathione and alpha-lipoate in diabetic rate: nerve function, blood flow and oxidative state. Eur J Clin Invest 31: 417-424.
8. Feldman EF. 2003. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 111: 431-433.
9. Park MJ, Song YS, Han JS. 2006. Protective effects of the BuOH fraction from Laminaria japonica extract on high glucose-induced oxidative stress in human umbilical vein endothelial cells. J Food Sci Nutr 11: 94-99.
10. Tsuneki H, Sekizaki N, Suzuki T, Kobayashi S, Wada T, Okamoto T, Kimura I, Sasaoka T. 2007. Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells. Eur J Pharmacol 566: 1-10.
11. Dewanjee S, Das AK, Sahu R, Gangopadhyay M. 2009. Antidiabetic activity of Diospyros peregrine fruit: effect on hyperglycemia, hyperlipidemia and augmented oxidative stress in experimental type 2 diabetes. Food Chem Toxicol 47: 2679-2685.
12. Saini AK, Arun KHS, Sharma SS. 2007. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. Eur J Pharmacol 568: 164-172.
13. Giugliano D, Ceriello A, Paolisso G. 1996. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257- 267.
14. Baynes JW, Thorpe SR. 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9.
15. Zanetti M, Zwacka R, Engelhardt J, Katusic Z, O'Brien T. 2001. Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia. Arterioscler Thromb Vasc Biol 21: 195-200.
16. Mineur F, Clerck OD, Roux AL, Maggs CA, Verlaque M. 2010. Polyopes lancifolius (Halymeniales, Rhodophyra), a new component of the Japanese marine flora introduced to Europe. Phycologia 49: 86-96.
17. Kim KY, Nguyen TH, Kurihara H, Kim SM. 2010. α-glucosidase inhibitory activity of bromophenol purified from the red alga Polyopes lancifolia. J Food Sci 75: 145-150.
18. Sevanian A, Hochstein P. 1985. Mechanism and consequence of lipid peroxidation in biological systems. Annu Rev Nutr 5: 365-390.
19. Schmidtmann S, Muller M, von Baehr R, Precht K. 1991. Changes of antioxidative homeostasis in patients on chronic haemodialysis. Nephrol Dial Transpl 6: 71-74.
20. Halliwell B, Gutteridge JMC. 1999. Free Radicals in Biology and Medicine. 3rd ed. Oxford University Press, Oxford, UK. p 617-783.
21. Seghrouchni I, Drai J, Bannier E, Riviere J, Calmard P, Garcia I, Orgiazzi J, Revol A. 2002. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 321: 89-96.
22. Lee YJ, Kang DG, Kim JS, Lee HS. 2008. Lycopus lucidus inhibits high glucoseinduced vascular inflammation in human umbilical vein endothelial cells. Vasc Pharmacol 48: 38-46.
23. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of aging. Nature 408: 239-247.
24. Pereira EC, Ferderbar S, Bertolami MC, Faludi AA, Monte O, Xavier HT, Pereira TV, Abdalla DS. 2008. Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus. Clin Biochem 41: 1454-1460.
25. Corbett JA, McDaniel ML. 1992. Does nitric oxide mediate autoimmune destruction on β-cells? Possible therapeutic interventions in IDDM. Diabetes 41: 897-903.
26. Hogg N, Darley-Usmar VM, Graham A, Moncada S. 1993. Peroxynitrite and atherosclerosis. Biochem Soc Trans 21: 358-362.
27. Lee SH, Han JS, Heo SJ, Hwang JY, Jeon YJ. 2009. Protective effects of dieckol isolated from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells. Toxicol In Vitro 24: 375-381.
28. Spencer NF, Poynter ME, Im SY, Daynes RA. 1997. Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol 9: 1581-1588.
29. Thiemermann C, Ruetten H, Wu CC, Vane JR. 1995. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845-2851.
30. Liaudet L, Rosselet A, Schaller MD, Markert M, Perret C, Feihl F. 1998. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis 177: 127-132.
31. Yokozawa T, Kim YA, Kim HY, Lee YA, Nonaka G. 2007. Protective effect of persimmon peel polyphenol against high glucose-induced oxidative stress in LLC-PK(1) cells. Food Chem Toxicol 45: 1979-1987.
32. Wu KK. 1995. Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 33: 179-190.
33. Baeuerle PA, Baltimore D. 1996. NF-kappa B: ten years after. Cell 87: 13-20.
34. Han M, Wen JK, Zheng B, Zhang DQ. 2004. Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sci 75: 675-684.
35. Du X, Stocklauser-Färber K, Rösen P. 1999. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic Biol Med 27: 752-763.
36. Hattori Y, Hattori S, Sato N, Kasai K. 2000. High-glucoseinduced nuclear factor kappa B activation in vascular smooth muscle cells. Cardiovasc Res 46: 188-197.
37. Morigi M, Angioletti S, Imberti B, Donatelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G. 1998. Leukocyte- endothelial interaction is augmented by high glucose concentration and hyperglycemia in a NF-κB dependent fashion. J Clin Invest 101: 1905-1915.